Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus - Publication - Bridge of Knowledge

Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

Abstract

Citations

1 6

CrossRef
0

Web of Science
1 5

Scopus

Authors (20)

Georg Hess
Simon Rule
Wojciech Jurczak MD, PhD, Prof
Mats Jerkeman
Rodrigo Santucci
Chiara Rusconi
Dolores Caballero
Cristina Joao
Mathias Witzens-Harig
Isabelle Bence-Bruckler
Seok-Goo Cho
Wenjiong Zhou
Jenna Goldberg
Cristina Trambitas
Christopher Enny
Jessica Vermeulen
Shana Traina
Chiun-Fang Chiou
Joris Diels
Martin Dreyling

Cite as

Full text

full text is not available in portal

full content of the article see on external site open in new tab

Details

Category:: Magazine publication
Type:: Magazine publication
Published in:: LEUKEMIA & LYMPHOMA no. 58, edition 12, pages 2824 - 2832,
ISSN: 1042-8194
ISSN:: 1042-8194
Publication year:: 2017
DOI:: Digital Object Identifier (open in new tab) 10.1080/10428194.2017.1326034
Verified by:: No verification

seen 103 times